Article Information
History
- April 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sushila Kataria1,*,
- Pooja Sharma2,
- Vikas Deswal1,
- Kuldeep Kumar3,
- Manish Singh3,
- Sazid Alam4,
- Vaibhav Gupta1,
- Padam Singh2,
- Rashmi Phogat5,
- Smita Sarma5,
- Nipun Patil4,
- Rohit Dutt6,
- Renu Saxena7 and
- Naresh Trehan4
- 1Internal Medicine, Medanta- The Medicity, Gurugram, Haryana, India
- 2Medanta Institute of Education and Research, Gurugram, Haryana, India
- 3Medanta Institute of Education and Research, Gurugram, Haryana, India, and PhD Scholar GD Goenka University
- 4Medanta- The Medicity, Gurugram, Haryana, India
- 5Department of Microbiology, Medanta- The Medicity, Gurugram, Haryana, India
- 6School of Medical and Allied Sciences, GD Goenka University, Gurugram, Haryana, India
- 7Laboratory Medicine, Medanta- The Medicity, Gurugram, Haryana, India
- ↵*Corresponding Author: Dr Sushila Kataria
; email: drsushilakataria{at}gmail.com
Posted April 20, 2021.
A Real World Evaluation of the safety and immunogenicity of the Covishield vaccine, ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) in Health Care Workers (HCW) in National Capital Region (NCR) of India: A preliminary report
